Dipna Pharmachem Limited has announced a board meeting on which it approved key leadership changes. Mr. Keyur Shah has been appointed as Chief Financial Officer, bringing over six years of pharma trading and finance experience. Mr. Parin Bhavsar joins as an Additional Non-Executive Independent Director with expertise in corporate law, GST, and startup advisory. Ms. Dipna Shah has been appointed Chairperson; she has 10+ years in pharma-chemical trading and finance, and is related to the Managing Director. The Nomination & Remuneration, Stakeholders Relationship, and Audit Committees have been reconstituted accordingly, with Mr. Nandish Jani as Chairperson and involvement of Ms. Shah and Mr. Bhavsar.